Liu Xin, Dai Chunsun
Center for Kidney Diseases, 2nd Affiliated Hospital, Nanjing Medical University, Nanjing, PR China.
Kidney Dis (Basel). 2017 Jan;2(4):187-196. doi: 10.1159/000449029. Epub 2016 Sep 7.
Residual renal function (RRF), defined as the ability of native kidneys to eliminate water and uremic toxins, is closely correlated with mortality and morbidity rates among patients receiving either peritoneal dialysis (PD) or hemodialysis (HD) via continuous clearance of middle-sized molecules and protein-bound solutes. Therefore, preserving RRF is considered to be one of the primary goals in managing patients with end-stage renal disease (ESRD).
In this article, we provide a review on the understanding and management of RRF in patients on dialysis. RRF may be estimated and measured by calculating the mean 24-hour urine creatinine level and urea clearance. Currently, several middle-sized molecules are reported but rarely used in practice. Many risk factors such as original renal diseases, dietary intake, and nephrotoxic agents impair RRF. Targeting such factors may halt the decline in RRF and offer better outcomes for patients on PD or HD. Except for in PD patients, RRF is a powerful predictor of survival in HD patients. RRF requires more clinical and research attention in the care of patients with ESRD on dialysis.
残余肾功能(RRF)定义为天然肾脏清除水分和尿毒症毒素的能力,通过持续清除中分子和蛋白结合溶质,它与接受腹膜透析(PD)或血液透析(HD)的患者的死亡率和发病率密切相关。因此,保留RRF被认为是管理终末期肾病(ESRD)患者的主要目标之一。
在本文中,我们对透析患者RRF的认识和管理进行了综述。RRF可以通过计算24小时平均尿肌酐水平和尿素清除率来估计和测量。目前,有几种中分子物质被报道,但在实践中很少使用。许多危险因素,如原发性肾脏疾病、饮食摄入和肾毒性药物,都会损害RRF。针对这些因素可能会阻止RRF下降,并为接受PD或HD的患者带来更好的结果。除了PD患者外,RRF是HD患者生存的有力预测指标。在透析的ESRD患者护理中,RRF需要更多的临床和研究关注。